Effect of ADC4022 Co-Administered With Budesonide on Pulmonary Inflammation in Subjects With Moderate to Severe COPD

Clinical trial NCT00634413 · COMPLETED

Trial details

NCT number: NCT00634413
Sponsor: Pulmagen Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease

Start date: 2008-02-01
Primary completion: 2008-12-01
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.